Oragenics Inc.

AMEX: OGEN · Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Aug 15, 2025, 3:59 PM
1.17
2.61%
After-hours: Aug 15, 2025, 07:37 PM EDT

Oragenics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-10.3M -10.33M -10.57M -19.97M -19.52M -20.26M -20.66M -8.21M -10.12M -11.1M -14.29M -16.28M -16.74M -16.53M -15.71M -17.83M -17.94M -26.46M
Depreciation & Amortization
771.44K 192.86K n/a n/a 4.79K 16.09K 27.39K 40.46K 48.43K 47.5K 44.67K 38.01K 34.91K 36.98K 41.24K 47.67K 50.9K 51.3K
Stock-Based Compensation
326.5K 377.94K 516.05K 928.67K 1M 1.01M 1.02M 450.94K 516.56K 731.92K 742.2K 1.07M 702.36K 654.51K 1.69M 1.73M 1.82M 1.75M
Other Working Capital
1.72M 1.54M 1.39M 83.92K 772.18K 1.7M 2.34M -1.85K -709.77K -2.01M -2.49M -196.23K -839.85K 920.33K 876.42K 849.59K 1.38M -810.21K
Other Non-Cash Items
181.25K 181.4K 181.4K 10.03M 9.83M 10.55M 10.55M -14.52M -11.78M -12.32M -12.33M -10.58M -12.77M -14.06M -12.53M 806.37K -321.21K 8.81M
Deferred Income Tax
n/a n/a n/a 476.04K 476.04K -243.74K -243.74K 14.5M 11.78M 12.5M 12.5M 10.76M 13.47M 13.47M 13.47M n/a n/a n/a
Change in Working Capital
1.61M 1.94M 1.27M 848.67K 992.86K 689.54K 2.02M -879.17K -1.34M -1.38M -1.72M 501.05K -66.08K 1.07M 512.14K 966.2K 1.5M -693.6K
Operating Cash Flow
-7.42M -7.65M -8.6M -7.68M -7.21M -8.25M -7.29M -8.62M -10.89M -11.7M -15.23M -14.68M -16.08M -14.78M -13.47M -15.22M -14.7M -17.46M
Capital Expenditures
3.00 3.00 3.00 5.00 5.00 5.00 5.00 -3.44K -40.47K -40.47K -127.52K -143.83K -130.92K -130.92K -43.88K -24.12K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a 63.71K 63.71K 63.71K 63.71K n/a n/a 12K 12K 12K 12K n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -1M -1M -1M -1M -127.52K -127.52K -127.52K -115.52K -31.88K -31.88K -31.88K -43.88K n/a n/a n/a
Investing Cash Flow
n/a n/a n/a -1M -936.28K -936.28K -936.28K 60.28K -40.47K -40.47K -115.52K -131.83K -118.92K -118.92K -43.88K -24.12K n/a n/a
Debt Repayment
1.65M 1.53M -693.11K -611K -611.11K -484.27K -458.16K -434.72K -420.54K -542.71K -382.96K -1M -901.19K -779.01K -779.01K n/a n/a 61.24K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.64M 5.64M 5.64M n/a -5.64M -5.64M -5.64M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.12M -1.78M -1.78M -1.78M
Other Financial Acitivies
-132.96K n/a n/a n/a n/a -107.89K -107.89K -107.89K -107.89K n/a -181.24K -181.24K -203.15K -50.89K 24.44M 36.33M 41.43M 41.3M
Financial Cash Flow
8.04M 8.99M 5.98M 6.06M 3.03M 2.1M 283.88K 376.48K -459.14K -473.43K -494.92K -585.76K -504.17K -229.74K 23.14M 34.55M 39.65M 39.59M
Net Cash Flow
625.12K 1.35M -2.62M -2.62M -5.13M -7.09M -7.94M -8.18M -11.39M -12.21M -15.84M -16M -16.71M -15.13M 9.63M 19.91M 24.95M 22.13M
Free Cash Flow
-7.42M -7.65M -8.6M -7.68M -7.21M -8.25M -7.29M -8.62M -10.93M -11.74M -15.36M -14.82M -16.22M -14.91M -13.51M -15.24M -14.7M -17.46M